AACR 2022: Roadmap to a Successful Biotech Start-up Journey
At the AACR Annual Meeting 2022, a special session, titled Fostering Entrepreneurship Part 1: Shopping Your Intellectual Property and Establishing Partnerships, focussed on encouraging new talents to enter the start-up space to innovate therapeutics. For scientists who are interested in starting their companies or taking their science to big pharma, experts from academia, industry and venture capital discussed some insightful learnings of navigating the entrepreneurial landscape in drug development.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115